{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:36:55Z","timestamp":1793144215905,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.xkme.2021.06.011","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T01:47:25Z","timestamp":1628473645000},"page":"1086-1090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Collapsing Focal Segmental Glomerulosclerosis and Acute Kidney Injury Associated With Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Case Report"],"prefix":"10.1016","volume":"3","author":[{"given":"Ratna","family":"Acharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-0220","authenticated-orcid":false,"given":"Kiran","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9967","key":"10.1016\/j.xkme.2021.06.011_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T\u00a0Cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.xkme.2021.06.011_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.xkme.2021.06.011_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2215\/CJN.12871117","article-title":"Chimeric antigen receptor T cell therapy and the kidney: what the nephrologist needs to know","volume":"13","author":"Jhaveri","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2021.06.011_bib4","first-page":"2386187","article-title":"Immunotherapy with CAR-modified T cells: toxicities and overcoming strategies","volume":"2018","author":"Sun","year":"2018","journal-title":"J\u00a0Immunol Res"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2021.06.011_bib5","first-page":"S42","article-title":"Toxicities of CD19 CAR-T cell immunotherapy","volume":"94","author":"Hirayama","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.xkme.2021.06.011_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.xkme.2021.06.011_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2020.07.025","article-title":"Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies","volume":"146","author":"Freyer","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.xkme.2021.06.011_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2021.06.011_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"JULIET Investigators. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.xkme.2021.06.011_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.ajkd.2019.10.011","article-title":"Acute kidney injury and electrolyte abnormalities after chimeric antigen receptor T-cell (CAR-T) therapy for diffuse large B-cell lymphoma","volume":"76","author":"Gupta","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2021.06.011_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbmt.2020.02.012","article-title":"Acute kidney injury after CAR-T cell therapy: low incidence and rapid recovery","volume":"26","author":"Gutgarts","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.xkme.2021.06.011_bib12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.ajkd.2020.08.017","article-title":"Acute kidney injury after the CAR-T therapy tisagenlecleucel","volume":"77","author":"Lee","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.xkme.2021.06.011_bib13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.ki.5000352","article-title":"Nephrotic syndrome associated with hemophagocytic syndrome","volume":"69","author":"Thaunat","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2021.06.011_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A\u00a0conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression","volume":"13","author":"Saleem","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2021.06.011_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1523-1755.2000.00870.x","article-title":"Dominant T cells in idiopathic nephrotic syndrome of childhood","volume":"57","author":"Frank","year":"2000","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2021.06.011_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00467-006-0026-5","article-title":"A\u00a0case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome","volume":"21","author":"Araya","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2021.06.011_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s004670050760","article-title":"Interleukin-8 alters glomerular heparan sulfate glycosaminoglycan chain size and charge in rats","volume":"14","author":"Garin","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.xkme.2021.06.011_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000186702","article-title":"Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats","volume":"60","author":"Tanaka","year":"1992","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.xkme.2021.06.011_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13730-014-0127-0","article-title":"Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis","volume":"3","author":"Yamada","year":"2014","journal-title":"CEN Case Rep"},{"issue":"3","key":"10.1016\/j.xkme.2021.06.011_bib20","first-page":"178","article-title":"Rapid and sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis","volume":"4","author":"De La Torre","year":"2011","journal-title":"NDT Plus"},{"issue":"1","key":"10.1016\/j.xkme.2021.06.011_bib21","first-page":"58","article-title":"Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys","volume":"69","author":"Fukatsu","year":"1993","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.xkme.2021.06.011_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00041552-200101000-00009","article-title":"Cytokine cross-talk between tubular epithelial cells and interstitial immunocompetent cells","volume":"10","author":"van Kooten","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"10.1016\/j.xkme.2021.06.011_bib23","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.4049\/jimmunol.164.6.3323","article-title":"Distinct T cell\/renal tubular epithelial cell interactions define differential chemokine production: implications for tubulointerstitial injury in chronic glomerulonephritides","volume":"164","author":"Kuroiwa","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.xkme.2021.06.011_bib24","doi-asserted-by":"crossref","first-page":"F1683","DOI":"10.1152\/ajprenal.00512.2017","article-title":"Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis","volume":"315","author":"Wright","year":"2018","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059521001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:23:19Z","timestamp":1762910599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059521001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2590059521001710"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2021.06.011","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collapsing Focal Segmental Glomerulosclerosis and Acute Kidney Injury Associated With Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2021.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}